Lung Cancers Completed Phase 2 Trials for Isotretinoin (DB00982)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00062010Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung CancerTreatment
NCT0000258613-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung CancerPrevention
NCT00002506Isotretinoin Plus Interferon in Treating Patients With Recurrent CancerTreatment